Skip to content

Faculty profile

Rachel Wevrick

Back to faculty
ResearcherMedical GeneticsUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Latest papers

  • Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome.

    Molecular therapy. Methods & clinical development · 2022

  • The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.

    The Journal of biological chemistry · 2021 · senior author

  • The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.

    Human genetics · 2020 · senior author

All 37 publications

Latest funding

  • Biological functions of melanoma antigen (MAGE) proteins

    NSERC · 2020 · Principal investigator

    $64,000
  • 9th International Prader Willi Syndrome Organisation Conference: 2016 Scientific Conference

    CIHR · 2016 · Nominated PI

    $8,500
  • Exploration of a melanoma antigen (MAGE)-E3 ubiquitin ligase circuit governing circadian rhythm

    NSERC · 2014 · Principal investigator

    $175,000
All 9 grants and awards
Something wrong or missing on this profile? Suggest a correction